The lymphocyte pore-forming protein perforin is essential for maintaining immune homeostasis and for effective defense against intracellular pathogens. To date, there have been no reported structure-function studies to substantiate the function of any putative domains of perforin, which have been postulated totally on primary sequence similarities with domains in other proteins. In this report, we have used recently developed modalities for expressing full-length perforin and robust functional assays to investigate one of the hallmarks of perforin function: its absolute dependence on calcium for lipid binding and cell lysis. We provide, for the first time, experimental evidence that the predicted C-terminal C2 motif constitutes a functional domain that is responsible for membrane binding of perforin. Whereas conserved aspartate residues at positions 429, 435, 483, and 485 were essential for calcium-dependent plasma membrane binding and cell lysis, the contribution of Asp-491 was limited. Finally, after experimentally verifying an optimized three-dimensional model, we have made predictions on the impact of two inherited perforin mutations of the C2 domain on calcium-dependent lipid binding and cell lysis.
Perforin is a calcium-dependent membrane-disruptive protein stored in the lysosome-like secretory granules of cytotoxic T lymphocytes (CTLs) 1 and natural killer cells (1) (2) (3) (4) (5) (6) . In response to the formation of an immunological synapse, perforin and pro-apoptotic serine proteases, granzymes, are released from the secretory granules and diffuse a short distance to the target cell (7) . Functional perforin is essential for granzymemediated death of virus-infected and transformed cells, through the induction of apoptosis. Mice deficient in perforin are susceptible to many viruses and to intracellular bacterial infections (8) , fail to reject transplanted tumors, and spontaneously develop aggressive B cell lymphoma as they age, indicating a fatal lapse of tumor immune surveillance (9) . Infants that inherit inactivating (frequently missense) mutations of both PFN1 alleles are unable to clear antigen-presenting cells recruited in response to viral antigens, typically in the first year of life (10 -12) . This causes an uncontrolled activation and accumulation of activated T cells and macrophages and overproduction of inflammatory cytokines that results in a fatal disorder known as familial hemophagocytic lymphohistiocytosis (FHL) (10 -12) .
Based on amino acid sequence alignment, perforin is predicted to be a multidomain protein with several putative functional motifs interspersed with other regions that have no significant likeness to known proteins (13) . These recognized motifs include an N-terminal region that possesses some intrinsic lytic capacity when it is synthesized as an oligopeptide (14, 15) ; an amphipathic ␣-helical domain, presumed to be important for membrane insertion of perforin; an epidermal growth factor-like domain of unknown function, and a carboxyl C2 domain predicted to bind calcium ions (16) . The central portion of perforin (comprising around one quarter of the molecule) shares some similarity with components of the complement membrane attack complex, particularly C9 (3, 17) , however, the complement proteins do not possess a C2 domain.
Despite the paramount importance of perforin in maintaining immune homeostasis, it has not been possible to substantiate the functions of putative perforin domains beyond identifying homologies with other characterized proteins. Such a large gap in our knowledge primarily exists due to the lack of appropriate methodologies for expressing, purifying, and testing recombinant perforin. Despite these drawbacks, many in vitro studies have been united in demonstrating the absolute dependence of perforin on calcium ions for its membrane binding and lytic function (18 -20) . Remarkably, the molecular basis for this requirement is still unclear, two decades after the initial isolation of the protein. More recently, structure prediction analysis has suggested that the C terminus of perforin may form a calcium-dependent membrane-binding C2 domain (16, 21, 22) . C2 domains have been found in a number of unrelated proteins, such as synaptotagmin, protein kinase C-␤ (PKC-␤), and phospholipase C-␦ (PLC-␦) (21, (23) (24) (25) (26) (27) (28) . Calciumbinding C2 domains coordinate calcium ions, usually through exposed carboxylic groups protruding from loops formed by the ␤-sheet scaffold of the motif. Calcium coordination in turn facilitates the binding of the C2 domain to phospholipid membranes. However, following the initial claims of perforin containing a C2 domain, there has been no experimental data verifying that this motif acts as a functional domain that can regulate the membrane binding perforin and subsequent cell lysis.
The current study represents the first comprehensive structure-function analysis aimed at understanding the structural basis of calcium-dependent membrane binding of perforin. Through a detailed mutational analysis and using our recently developed methodologies (29) , we now experimentally demonstrate the essential role of the C2 domain for cell membrane binding and cytotoxic function of perforin. Based on the solved structures of other C2 domains, we have also built and experimentally validated three-dimensional models of the C2 domain and suggest plausible molecular explanations for two FHL-associated mutations mapping to the C2 domain.
MATERIALS AND METHODS
Cell Culture-Adherent RBL-2H3 (RBL; rat basophil leukemia, American Type Culture Collection, National Institutes of Health) and non-adherent Jurkat human T lymphoma cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 2 mM glutamine at 37°C. RBL cells were harvested by brief incubation in trypsin-EDTA solution (CSL Ltd., Australia) at 37°C and were thoroughly washed prior to use in cytotoxicity assays.
Transient Transfection of RBL Cells and Cytotoxicity Assays-Mouse perforin cDNA in pKS(ϩ) Bluescript was mutated using the Transformer or QuikChange kits according to the manufacturer's instructions (Stratagene) (oligonucleotide primer sequences will be provided on request). The wild-type (wt) or mutated perforins G428E, G428D, G428A, G428K, D429A, T434M, T434D, T434K, D435A, D483A, D485A, D489A, D490A, D491A, and D497A (referred to as such in the text) were cloned into the pIRES2-epidermal growth factorP expression plasmid (BD Biosciences Clontech). This vector contains an internal ribosome entry site, which allows the selection of perforin-expressing cells based on green fluorescent protein expression (29) . Each perforin cDNA was sequenced in full on both strands to check the fidelity of site-directed mutagenesis. The resultant expression plasmids were purified using Qiagen Maxi-kit. Fc⑀-expressing RBL cells were transiently transfected with 20 g of pIRES2-epidermal growth factorP containing perforin cDNA or the vector alone (green fluorescent protein control) as described previously (29) . Green fluorescent protein-expressing cells were collected 18 -20 h later using flow cytometry (FACStar, BD Biosciences). The cytotoxic capacity of RBL cells was analyzed using Jurkat T cells as targets in a 4-h 51 Cr release assay as described previously (Voskoboinik et al. (29) and Shiver et al. (40) ).
Expression of Recombinant Perforin, Membrane Binding, and Cytotoxicity Assays-wt, D429A, D435A, D483A, D485A, and D491A perforin cDNAs were cloned into the pFastBac vector and overexpressed in Sf21 cells using the Back-to-Back kit. Perforin was purified according to the manufacturer's instructions (all additional reagents were supplied by Invitrogen). In the membrane binding assay, 2 ϫ 10 7 sheep red blood cells (SRBCs) were resuspended in 200 l of buffer containing 150 mM NaCl, 1 mM CaCl 2 , and 20 mM Hepes (pH7.2), unless otherwise stated. An aliquot of purified perforin was added to the cell suspension for 5 min on ice. The cells were pelleted at 12,000 ϫ g for 10 s in a microcentrifuge, the supernatant was promptly removed, and the cells were washed in ice-cold buffer, lysed in SDS-PAGE loading buffer, and analyzed by Western immunoblotting. The SRBC lysis assay was performed in the same buffer at 37°C for 20 min in U-shaped 96-well plates, unless otherwise stated. Following centrifugation at 1,500 ϫ g for 5 min, the release of hemoglobin into the supernatant was estimated by measuring absorbance at 405 nm. Cell lysis was expressed as a percentage of maximum hemoglobin release compared with lysis in water.
Immunoperoxidase Staining-Approximately 100,000 RBL cells were seeded in each well of an eight-well chamber slide 1 day prior to staining. Cells were fixed for 10 min at room temperature in 3.7% paraformaldehyde/phosphate-buffered saline, washed three times in phosphate-buffered saline, permeabilized in 0.1% Triton X-100, 0.5% bovine serum albumin for 5 min, then washed as before. Endogenous peroxidase activity was quenched with 0.3% H 2 O 2 for 15 min. Blocking buffer (1% bovine serum albumin or skim milk powder in phosphate- siently transfected RBL cells or recombinant purified perforin were resolved on 10% SDS-PAGE (Tris-glycine) gels, which were then analyzed for perforin expression by immunoblotting with P1-8 and horseradish peroxidase-conjugated rabbit anti-rat Ig. The signal was detected by chemiluminescence (Amersham Biosciences).
Three-dimensional Modeling of the Putative Calcium-binding Domain of Perforin-To rationalize the effects of various mutations, homology models of the perforin C2 domain were constructed using four known C2 domain-containing structures: protein kinase C-␤ (Protein Data Bank ID 1A25 (26)), phospholipase C-␦ (1DJG (28)), phospholipase A2 (1RLW (30)), and synaptotagmin-III C (1DQV (27) ). Each of the selected templates is a high resolution structure determined by x-ray crystallography and containing multiple bound divalent cations. Using the convention of Essen et al. (28) and Sutton and Sprang (26) , the four calcium binding sites observed in C2 domains were numbered I-IV. Data presented in Table I highlight the calcium binding sites occupied in each of the template structures. Target-template alignments were carried out manually and were based on both sequence and secondary structure, but without access to the results of biological experiments herein. Perforin secondary structure was predicted using JPRED (31) . Modeling was carried out using standard protocols in MODELLER (32) and structures analyzed in VMD (33) . The effects of mutations in the model structures were predicted by replacing the wt residue with the mutant residue in commonly occurring rotamers.
RESULTS
Recombinant Purified Perforin Has Potent Lytic Activity-To perform a detailed structure-function analysis of perforin, we needed to design an experimental system that would allow the expression and purification of recombinant perforin for use in cell free assays. There was also a need to validate the function of the recombinant product. Recently we reported such a system, which is based on the expression of perforin in baculovirus-infected insect cells (29) . Although the yield of purified perforin was relatively low (40 -120 g/liter culture), the product contained minimal contaminants or degradation products (data not shown) and was strongly antigenic with anti-perforin antisera ( Fig. 1 and see below) . The lytic activity associated with each elution fraction was also closely correlated with perforin concentration (data not shown). We assessed the potency of recombinant wt perforin and found that ϳ35 fmol (corresponding to a perforin concentration of 175 pM) was sufficient to induce the release of half the total hemoglobin contained in 2.5 ϫ 10 7 SRBC (Fig. 1A ). This level of activity corresponds to ϳ750 perforin molecules per cell, assuming that all become membrane-bound. Lytic activity was maximal within 2-4 min, upon perforin addition. These results confirmed the potency of the recombinant perforin and were consistent with earlier studies (18) . In agreement with earlier reports using semi-purified native perforin (18 -20) , erythrocyte lysis was Ca 2ϩ -dependent, with maximal hemoglobin release observed at Ͼ200 M, and 50% lysis at around 70 M Ca 2ϩ (Fig. 1B) . Importantly, these data were consistent with calciumdependent membrane binding of perforin to SRBC, in that maximal binding occurred at ϳ200 M Ca 2ϩ (Fig. 1B) . Also consistent with earlier findings using purified native perforin (18) , the binding of perforin was completely reversed when Ca 2ϩ was chelated with EGTA, resulting in abrogation of further cell lysis.
Positively charged calcium ions are commonly coordinated in proteins by amino acids with an acidic moiety. Protonation of acidic side chains due to reduction in the pH would therefore be expected to reduce Ca 2ϩ binding to perforin, leading to reduced capacity to bind lipid membranes and induce cell lysis. Indeed, as the pH was progressively reduced, the lytic activity of perforin also became reduced, with complete loss of function below pH 6.2 ( Fig. 1C (19) ). Although the mean pK a for aspartates is typically around 3.4, it is not uncommon for active site or ligand binding site carboxyl groups to have pK a values Ͼ5.5 (34). As discussed further below, we note that the pH of CTL granules is ϳ5.5, a level at which our data showed perforin would be inactive. Sublytic concentrations of recombinant perforin also efficiently delivered granzymes to induce apoptosis in a variety of cell lines (35) . Taken together, the characterized recombinant perforin was essentially indistinguishable, in terms of its fundamental lytic properties, from the native perforin described in earlier studies.
The Putative C2 Domain of Perforin Is Functionally ActiveThe amino acid sequence alignment of perforin with a number of calcium-binding C2 domains, including perforin homologues across various species, has previously revealed highly conserved aspartate residues at positions 429, 435, 483, 485, 489, 490, 491, and 497 (16, 21, 22) . Due to low overall similarity between C2 domains, we could not rule out any of these residues as potential calcium-binding ligands. The relative contribution of each aspartate residue to perforin function was investigated by substituting single aspartate residues with alanine and using transfection to express each perforin variant independently in RBL cells. We then assessed the capacity of each RBL cell population to kill 51 Cr-labeled Jurkat target cells to which they were conjugated. The mutations, D429A, D435A, D483A, and D485A, each caused the total loss of cytotoxic activity of perforin ( Fig. 2A) . By comparison, the replacement of aspartate residues at positions 465, which is conserved only in mammalian perforins, and at 489, 490, 491, and 497 had no effect on the cytolytic function of perforin-expressing RBL cells ( Fig. 2A) . Loss of perforin activity could not be put down to low expression levels or defective intracellular trafficking, as evident from Western blotting of RBL cell lysates and immunocytochemistry analysis (Fig. 2B) . Rather, we hypothesized that the loss of lytic function was related to the lack of calcium-dependent cell membrane binding.
To directly study cell membrane binding, we also expressed and purified each inactive, mutated perforin protein from baculovirus-infected insect cells (29) . Consistent with the results of the RBL cytotoxicity assay, the mutations D429A, D435A, D483A, and D485A led to a complete loss of cytolytic activity of recombinant perforins (data not shown). Subsequent analysis revealed that the lack of cytolytic activity was caused by the inability of these variants to fulfill the first crucial step in perforin-induced cytolysis, namely calcium-dependent membrane binding (Fig. 2A) . Whereas essentially all of the added wt 
a Proposed from mutagenesis and functional data in the present study. Protein kinase C-␤  II, III  II  II, III  II, III, IV  III, IV  Phospholipase C-␦  III  I, II  II, III  II, III  III  Synaptotagmin-IIIC2A  II, III  II  III  III, IV  IV perforin was bound to SRBC membranes in a calcium-dependent manner, substitution at residues 429, 435, 483, or 485 resulted in virtually complete loss of lipid binding ( Fig. 2A) . This finding strongly suggested that residues Asp-429, Asp-435, Asp-483, and Asp-485 were likely be direct ligands for Ca 2ϩ in the C2 domain. On the basis of the results of the experiments described above, amino acid sequence alignment and predicted secondary structure, we next built new three-dimensional models of the perforin C2 domain, using four templates, PLA2, PKC-␤, PLC-␦, and synaptotagmin IIIC (see "Materials and Methods"). A priori, we suspected that a model based on PLA2 would be less informative because, unlike the other three models, it suggested no role for the essential Asp-429 residue, and it appeared to coordinate two rather than three Ca 2ϩ ions (Tables  I and II) . Consistent with our experimental data, the other three models, protein kinase C-␤ (26), phospholipase C-␦ (28), and synaptotagmin-III C (27), predicted a critical role for aspartate residues Asp-429, Asp-435, Asp-483, and Asp-485 (Table II). In agreement with our data for the non-essential aspartate residues (Fig. 2A) , all of the C2 domain models predict that Asp-465 and Asp-497 are both remote from the Ca 2ϩ binding site and that the Asp-489 and Asp-490 side chains are oriented away from the binding site (Fig. 3) .
TABLE II Predicted participation of aspartate residues in calcium coordination at sites I-IV of the perforin C2 domain, based on several templates
Residue Asp-491 Is a Part of the C2 Domain-The most surprising finding was that Asp-491 appeared to be dispensable for perforin function under the conditions of the assay ( Fig.  2A) but was predicted to ligate calcium at sites III and/or IV (Fig. 3, top, and Table II) . One possible explanation was that Asp-491 is not actually a calcium ligand, or that it has a relatively minor role in calcium coordination compared with other critical aspartate residues. Another possibility is that the involvement of Asp-491 was masked by the relatively high calcium concentration in the assay. To address this, we modified the RBL cell-based assay to account for the potentially reduced affinity of D491A perforin for Ca 2ϩ . By depleting extracellular calcium through the progressive addition of the calcium chelator EGTA, we found that the cytotoxicity of wt perforin-expressing RBL cells remained unaffected even when free calcium was reduced to 0.3 mM (Fig. 4) . In contrast, D491A-expressing RBL cells displayed reduced cytotoxicity in the presence of 0.8 mM free Ca 2ϩ , and the cytotoxicity was abolished completely in the presence of 0.3 mM free Ca 2ϩ (Fig. 4) . This was an intriguing finding because, unlike other critical aspartate residues, Asp-491 appeared to be non-essential for the cytotoxicity of perforin under high calcium concentrations but played a critical role under calcium-limiting conditions. To elucidate the effect of D491A substitution on membrane-binding properties of perforin, we conducted direct membrane binding studies using purified recombinant D491A. Even though the D491A mutant appeared to be fully active in the presence of 1 mM calcium in the RBL cell-based system, the membrane binding of purified protein was significantly reduced compared with the wt perforin (Fig. 4) . Overall, these findings were consistent with the structure prediction analysis in that Asp-491 was an integral part of calcium binding loop in the C2 domain of perforin.
Two Inherited Mutations of the C2 Domain of Perforin and Their Impact on Cell Lysis-Two FHL-associated missense mutations have been identified in the C2 domain of perforin, both directly adjacent to different critical aspartate residues. Recently we reported that one of these mutations, G428E (adjacent to Asp-429), results in a significant reduction (but not the total loss) of cytotoxicity. This was found to be caused by significantly compromised calcium-dependent plasma membrane binding of the mutated perforin compared with the wt perforin (29) . To gain further insight into the reduced membrane binding of G428E perforin, the three-dimensional models were used to analyze possible structural consequences of the G428E substitution (Fig. 5A) . In two of the models (based on PKC-␤ or PLC-␦ templates), Gly-428 was located in the first calcium-binding loop, with its C␣ atom 4 -7 Å from the nearest calcium atom. Replacing glycine with a much larger amino acid would be expected to lead to protrusion of the amino acid side chain into the calcium-binding cleft. Although smaller substitutions might be tolerated, larger substitutions, particularly to basic residues, would likely interfere with calcium binding at site III (Fig. 5) . In contrast to our experimental data, the synaptotagmin-III-based model predicted that Gly-428 mutations would not have any effect on perforin function (model not shown).
To further characterize the reduced membrane binding of G428E and to test the accuracy of our structural predictions, we generated a range of Gly-428 substitutions that incorporate diverse side chains. We introduced either a small side chain at position 428 (G428D and G428A) or a large, positively charged one (G428K), and tested them in the RBL-based cytotoxicity assay. Consistent with the predictions of all three models, both G428D and G428A resulted in normal cytotoxicity, whereas the G428K substitution completely abrogated target cell death (Fig. 6) .
Another FHL-associated mutation neighboring an essential aspartate residue within the C2 domain has been reported recently, T434M (36). When we tested this mutation, we were surprised to find T434M perforin had normal activity (Fig. 6) . Although the authors did not perform functional studies with T434M perforin, they proposed that the mutation would result in loss of calcium binding, based on their three-dimensional C2 domain model. The structure presented by McCormick and colleagues based on PLC-␦ (36) is in conflict with our structure prediction, in that we predict that Thr-434 lies at the base of the calcium-binding cleft, where methionine would be accommodated without disrupting the calcium binding site. In contrast, mutation to larger or basic amino acids would be predicted to impinge on critical calcium-binding aspartate residues (Fig. 5C ). In accord with our predictions, the RBLbased cytotoxicity assay demonstrated that neither the T434M nor T434D mutation had any significant effect on perforin function, whereas expression of T434K perforin resulted in complete loss of cytotoxicity (Fig. 6 ).
DISCUSSION
The current study is the first systematic molecular analysis of perforin, in which we have established the calcium-dependent C2 domain at the C terminus of perforin as a functional domain, which is responsible for the binding of perforin to target cell membranes and subsequent cytotoxic activity. We performed a detailed mutational analysis to identify and characterize critical aspartate residues of the C2 domain. These findings were further supported by structure prediction analysis using several solved C2 domains as templates. Two FHLassociated mutations mapping to the C2 domain were also functionally analyzed, and the experimental data were plausibly explained by our models.
Consistent with the theoretically predicted roles of Asp-429, Asp-435, Asp-483, and Asp-485 in calcium binding (16, 21, 22) , our results showed that mutation of these aspartate residues to alanine resulted in a loss of membrane binding and cytolytic activity. Interestingly, Asp-491 was initially shown to be nonessential for perforin function under high calcium concentrations, despite being predicted to ligate calcium at sites III and IV in several C2 domain templates. We therefore hypothesized that D491A might contribute to calcium binding, but may be dispensable at the relatively high calcium concentrations used in our cytotoxicity experiments. Although we produced each of the corresponding recombinant proteins, the low affinity of perforin for calcium prevented us from directly measuring calcium binding. Instead, we progressively reduced the concentration of bio-available calcium in the cytotoxicity assay and discovered that Asp-491 appeared to be dispensable at high calcium concentrations (Ն1 mM) but essential for perforin activity under submillimolar levels of Ca 2ϩ . In addition, calciumdependent plasma membrane binding of purified D491A was severely compromised compared with the wt protein thus supporting further the contribution of Asp-491 to calcium binding in the C2 domain of perforin.
Commonly, C2 domain-containing proteins operate inside cells, where the low calcium concentration determines their relatively high affinity for Ca 2ϩ (typically sub-to low micromolar levels). By contrast, perforin exerts its lytic activity within the synaptic cleft upon its secretion from cytolytic granules. Although calcium levels have never been formally measured in this diffusion-limited space, extracellular free calcium concen- trations are much higher, around 1.3 mM in plasma (37) , than inside the cell (typically between 100 nM in resting and 2.5 M in activated lymphocytes (38) ). It is, therefore, not surprising that others and we have found that a minimum of 200 M free Ca 2ϩ is required for full perforin activity. Indeed, due to its membrane-disrupting properties, avid calcium binding and perforin activation might be damaging to CTL/natural killer cells, if it occurred prior to degranulation. Furthermore, under acidic conditions, which mimic the environment in cytolytic granules, perforin was found to lose its cytolytic function even in the presence of elevated calcium. Because our mutational analysis demonstrates that only calcium-dependent membrane binding through the C2 domain provides perforin with a favorable conformation for exerting its lytic function, we propose that the low pH milieu of the granule might act as a built-in safeguard that provides protection against inadvertent perforin damage prior to release from the effector cell.
Previously we have characterized G428E-mutated perforin, which was identified in a FHL patient. We showed that the mutation causes a marked reduction in calcium-dependent membrane binding (29) . To better understand this effect, we modeled several other substitutions at Gly-428, incorporating diverse amino acid side chains, and then tested our predictions experimentally. The modeling on PLC-␦ and PKC-␤ suggested that the G428A or G428D substitutions might be accommodated without influencing calcium binding. However, progressively longer side chains (such as glutamate in the case of the FHL patient) would be more difficult to accommodate without structural perturbation. The inhibitory effect of the G428E mutation might also be explained by the introduction of an extra calcium ligand that interfered with potentially cooperative calcium binding. The introduction of a large basic lysine side chain was predicted to inhibit calcium binding and, indeed, was supported by our experimental data. Based on amino acid alignments, it has variously been proposed that synaptotagmin or phospholipase C-␦ adequately model the putative C2 domain of perforin (22) . Our current and previous studies (29) have ruled out the synaptotagmin-based model for perforin, which predicted no effect of Gly-428 substitutions on calcium binding sites. Furthermore, we find no experimental evidence that would favor PLC-␦-over the PKC-␤-based models.
Another missense mutation in the C2 domain, T434M, has been proposed to cause disruption of calcium binding. The only foundation for such a prediction was the PLC-␦-based threedimensional model of the mutated C2 domain (36) . However, our experimental data did not identify reduced perforin function when this mutation was introduced. Consistent with these observations our working three-dimensional models also sug- FIG. 5 . Rationalizing the effects of mutations at Gly-428 and Thr-434 in perforin. A, modeling of a G428E mutation suggests that Glu-428 would be positioned to interfere with the calcium binding sites. Likewise in B, a T434K mutation might also disrupt binding via electrostatic interactions with nearby calcium ligands such as Asp-483. In contrast, mutation to methionine is predicted to have a far less disruptive influence on the binding site, with the methionine side chain accommodated below the plane of the calcium ions.
gest that the substitution of threonine to neutral methionine or to aspartate would not be expected to impinge significantly on the binding site. In contrast, substitution to lysine was expected to cause the loss of activity, because the location of Thr-434 at the base of the calcium binding site suggests that introduction of the positive charge might distort the calcium binding site through electrostatic interaction. Once again, our experimentally verified structure prediction model was in stark contrast with the theoretical one published by the authors of the original report (36) . On the basis of our data we concluded, contrary to the original predictions (36) , that the T434M mutation alone is unlikely to play a causative role in FHL. In fact, the authors also reported an abnormal CD45 genotype in the same patient, and this might well result in significant immune dysfunction. Recently, evidence has emerged that FHL may be also caused by one or more mechanisms other than mutations in perforin (12, 39) . However, as mutations in the perforin gene were found in as many as 60% of FHL cases (12) , investigating the structure-function relationship of perforin should aid in understanding the effects of suspected disease-causing mutations at the molecular level.
In conclusion, we have conducted the first structure-function analysis of perforin, which provided an experimental foundation for decoding its molecular and cellular functions. This should pave the way toward a better understanding of lymphocyte biology and the regulation of immune homeostasis. 
